Skip to main content

Table 3 Major postoperative morbidity. Univariable analysis

From: Short-term postoperative outcomes of gastric adenocarcinoma patients treated with curative intent in low-volume centers

 

No

Yes

p value

n = 437 (73.9%)

n = 154 (26.1%)

Age (years)

70 (61–79)

74 (65–81)

0.012

Age categories

  

0.039

 < 75

263 (77.1%)

78 (22.9%)

 

 ≥ 75

174 (69.6%)

76 (30.4%)

 

Sex

  

0.07

 Men

259 (71.3%)

104 (28.7%)

 

 Women

178 (78.1%)

50 (21.9%)

 

Location

  

0.084

 GEJ-SIII type

27 (62.8%)

16 (37.2%)

 

 Gastric

410 (74.8%)

138 (25.2%)

 

ASA score

  

0.034

 I

33 (76.7%)

10 (23.3%)

 

 II

189 (78.4)

52 (21.6%)

 

 III

200 (71.2%)

81 (28.8%)

 

 IV

13 (54.2%)

11 (45.8%)

 

Charlson

1 (0–2)

1 (0–2)

0.52

Charlson categories

  

0.896

 No or low (0–1)

247 (74.4%)

85 (25.6%)

 

 Medium (2)

83 (72.2%)

32 (27.8%)

 

 High (> 2)

104 (73.8%)

37 (26.2%)

 

Neoadjuvant therapy

  

0.036

 No

303 (71.5%)

121 (28.5%)

 

 Yes

128 (80%)

32 (20%)

 

Laparoscopic approach

  

0.022

 No

400 (75.3%)

131 (24.7%)

 

 Yes

37 (61.7%)

23 (38.3%)

 

Gastrectomy

  

0.015

 Proximal

1 (25%)

3 (75%)

 

 Distal subtotal

232 (77.6%)

67 (22.4%)

 

 Total

202 (70.9%)

83 (29.1%)

 

Resection

  

0.784

 R0

414 (74.1%)

145 (25.9%)

 

 R1

23 (71.9%)

9 (28.1%)

 

Lymphadenectomy

  

0.085

 D0–D1

99 (69.2%)

44 (30.8%)

 

 D1+ or more

336 (75.5%)

109 (24.5%)

 

pTNM classification

  

0.739

 0

10 (90.9%)

1 (9.1%)

 

 IA

51 (70.8%)

21 (29.2%)

 

 IB

65 (75.6%)

21 (24.4%)

 

 IIA

69 (79.3%)

18 (20.7%)

 

 IIB

69 (71.1%)

28 (28.9%)

 

 IIIA

54 (74%)

19 (26%)

 

 IIIB

67 (73.6%)

24 (26.4%)

 

 IIIC

52 (70.3%)

22 (29.7%)

 

Annual hospital volume

  

0.791

 < 10

165 (73.3%)

60 (26.7%)

 

 ≥ 10

272 (74.3%)

94 (25.7%)

 
  1. GEJ-SIII type gastroesophageal junction Siewert type III, ASA American Society of Anesthesiologists classification